Skip to main content

Welkom bij Erasmus MC & Bohn Stafleu van Loghum

Erasmus MC heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen. Je kunt je links eenvoudig registreren. Met deze gegevens kun je thuis, of waar ook ter wereld toegang krijgen tot Mijn BSL.

Registreer

Om ook buiten de locaties van Erasmus MC, thuis bijvoorbeeld, van Mijn BSL gebruik te kunnen maken, moet je jezelf eenmalig registreren. Dit kan alleen vanaf een computer op een van de locaties van Erasmus MC.

Eenmaal geregistreerd kun je thuis of waar ook ter wereld onbeperkt toegang krijgen tot Mijn BSL.

Login

Als u al geregistreerd bent, hoeft u alleen maar in te loggen om onbeperkt toegang te krijgen tot Mijn BSL.

Top
Gepubliceerd in:

01-02-2006 | Tuberculose in Nederland

De diagnostiek en behandeling van latente tuberculose-infectie in kinderen

Auteurs: N A. H. van Hest, R. van Altena, S. M. Arend, H. W. M. Baars, J. H. van Loenhout-Rooyackers, N. G. Hartwig

Gepubliceerd in: Tijdschrift voor Kindergeneeskunde | Uitgave 1/2006

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Summary

More often than active tuberculosis disease children have latent tuberculosis infection (ltbi), which can occur after contact with a patient suffering from smear-positive pulmonary tuberculosis, usually an adult household member. In young children the infection is almost always recently acquired. Compared to adults, infected children, especially children with an immune disorder, have an increased risk of progression to active tuberculosis disease, and will more frequently develop severe manifestations of tuberculosis, such as tuberculous meningitis or miliary tuberculosis. Treatment of ltbi considerably reduces the risk of progression to active disease. Most infected children are identified during contact investigations or immigration screening and treated by the Department of Tuberculosis Control of the Municipal Health Service. The tuberculin skin test is not always a reliable method to diagnose ltbi, particularly in children with a previous bcg vaccination or in children with a reduced immune response. Recently developed interferon-? tests may contribute to improved diagnosis of ltbi in the future. On account of the publication of new guidelines for diagnosis and treatment of ltbi in children in the United States as well as in the Netherlands, the policies and developments in the Netherlands are discussed.
Literatuur
go back to reference KNCV Tuberculosefonds. Index tuberculosis 2001–2002. Den Haag: KNCV Tuberculosefonds, 2005. KNCV Tuberculosefonds. Index tuberculosis 2001–2002. Den Haag: KNCV Tuberculosefonds, 2005.
go back to reference Geuns HA van, Meijer J, Styblo K. Results of contact examination in Rotterdam, 1967–1969. Bull Int Union Tuberc 1975;50:107-21.PubMed Geuns HA van, Meijer J, Styblo K. Results of contact examination in Rotterdam, 1967–1969. Bull Int Union Tuberc 1975;50:107-21.PubMed
go back to reference Pediatric Tuberculosis Collaborative Group. Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents. Pediatrics 2004;114;1175-201.CrossRef Pediatric Tuberculosis Collaborative Group. Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents. Pediatrics 2004;114;1175-201.CrossRef
go back to reference Miller FJW, Scale ME, Taylor NM. Tuberculosis in children. Boston: Little, Brown, 1963. Miller FJW, Scale ME, Taylor NM. Tuberculosis in children. Boston: Little, Brown, 1963.
go back to reference Altena R van. Tuberculosebehandeling nieuwe stijl. In: Jongste JC de, Groot R de, Verduin CM, red. Behandelingsstrategieën bij kinderen met luchtweginfecties. Houten: Bohn Stafleu Van Loghum, 1999. Altena R van. Tuberculosebehandeling nieuwe stijl. In: Jongste JC de, Groot R de, Verduin CM, red. Behandelingsstrategieën bij kinderen met luchtweginfecties. Houten: Bohn Stafleu Van Loghum, 1999.
go back to reference American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-47.CrossRef American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000;161:S221-47.CrossRef
go back to reference Commissie voor Praktische Tuberculosebestrijding. De tuberculine huidtest. Den Haag: KNCV Tuberculosefonds, 2001. Commissie voor Praktische Tuberculosebestrijding. De tuberculine huidtest. Den Haag: KNCV Tuberculosefonds, 2001.
go back to reference Verver S. Epidemiology of tuberculosis among immigrants in the Netherlands and in a high incidence area in South Africa [Thesis]. Amsterdam: Universiteit van Amsterdam, 2004. Verver S. Epidemiology of tuberculosis among immigrants in the Netherlands and in a high incidence area in South Africa [Thesis]. Amsterdam: Universiteit van Amsterdam, 2004.
go back to reference Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356:1099-104.CrossRef Andersen P, Munk ME, Pollock JM, et al. Specific immune-based diagnosis of tuberculosis. Lancet 2000;356:1099-104.CrossRef
go back to reference Arend, SM. Cellular immune responses to mycobacteria: towards specific immunodiagnosis and protection [Thesis]. Leiden: Leids Universitair Medisch Centrum, 2002. Arend, SM. Cellular immune responses to mycobacteria: towards specific immunodiagnosis and protection [Thesis]. Leiden: Leids Universitair Medisch Centrum, 2002.
go back to reference Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004;170:59-64.CrossRef Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 2004;170:59-64.CrossRef
go back to reference Brock I, Weldingh K, Leyten EM, et al. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol 2004;42:2379-87.CrossRef Brock I, Weldingh K, Leyten EM, et al. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol 2004;42:2379-87.CrossRef
go back to reference Barnes PF. Diagnosing latent tuberculosis infection: turning glitter to gold. Am J Respir Crit Care Med 2004;170:5-6.CrossRef Barnes PF. Diagnosing latent tuberculosis infection: turning glitter to gold. Am J Respir Crit Care Med 2004;170:5-6.CrossRef
go back to reference Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001;357:2017-21.CrossRef Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001;357:2017-21.CrossRef
go back to reference Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361:1168-73.CrossRef Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361:1168-73.CrossRef
go back to reference Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002;16:2285-93.CrossRef Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002;16:2285-93.CrossRef
go back to reference Liebeschuetz S, Bamber S, Ewer K, et al Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004;364:2196-203.CrossRef Liebeschuetz S, Bamber S, Ewer K, et al Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004;364:2196-203.CrossRef
go back to reference Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWR Recomm Rep 2003;52(RR-II):15-8. Centers for Disease Control and Prevention. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. MMWR Recomm Rep 2003;52(RR-II):15-8.
go back to reference Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998;53:536-48.CrossRef Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998;53:536-48.CrossRef
go back to reference Centers for Disease Control and Prevention. Update: Adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection-United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:735-9. Centers for Disease Control and Prevention. Update: Adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection-United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52:735-9.
go back to reference Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999;3:847-50.PubMed Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis 1999;3:847-50.PubMed
go back to reference International Union against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five year of follow-up in the IUAT trial. Bull World Health Organ 1982;60:555-64.PubMedCentral International Union against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five year of follow-up in the IUAT trial. Bull World Health Organ 1982;60:555-64.PubMedCentral
go back to reference Comstock GW, Hammes LM, Pio A. Isoniazid prophylaxis in Alaskan boarding schools: a comparison of two doses. Am Rev Resp Dis 1969;100:773-9.PubMed Comstock GW, Hammes LM, Pio A. Isoniazid prophylaxis in Alaskan boarding schools: a comparison of two doses. Am Rev Resp Dis 1969;100:773-9.PubMed
go back to reference Mount FW, Ferrebee SH. Preventive effects of isoniazid in the treatment of primary tuberculosis in children. N Engl J Med 1961;265:713-21.CrossRef Mount FW, Ferrebee SH. Preventive effects of isoniazid in the treatment of primary tuberculosis in children. N Engl J Med 1961;265:713-21.CrossRef
go back to reference Ena J, Valls V. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: A meta-analysis. Clin Infect Dis 2005;40:670-6.CrossRef Ena J, Valls V. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: A meta-analysis. Clin Infect Dis 2005;40:670-6.CrossRef
go back to reference Ormerod LP. Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis. Arch Dis Child 1998;78:169-71.CrossRef Ormerod LP. Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis. Arch Dis Child 1998;78:169-71.CrossRef
go back to reference Reichman LB, Lardizabal A, Hayden CH. Considering the role of four months of rifampin in the treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2004;170:832-5.CrossRef Reichman LB, Lardizabal A, Hayden CH. Considering the role of four months of rifampin in the treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2004;170:832-5.CrossRef
go back to reference Menzies D, Dion MJ, Rabinovitch B, et al. Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months. Am J Respir Crit Care Med 2004:15;170:445-9.CrossRef Menzies D, Dion MJ, Rabinovitch B, et al. Treatment completion and costs of a randomized trial of rifampin for 4 months versus isoniazid for 9 months. Am J Respir Crit Care Med 2004:15;170:445-9.CrossRef
go back to reference Villarino ME, Ridzon R, Weismuller PC, et al. Rifampicine preventive therapy for tuberculosis infection: experience with 157 adolescents. Am J Resp Crit Care Med 1997;155:1735-8.CrossRef Villarino ME, Ridzon R, Weismuller PC, et al. Rifampicine preventive therapy for tuberculosis infection: experience with 157 adolescents. Am J Resp Crit Care Med 1997;155:1735-8.CrossRef
go back to reference Kopanoff DE, Snider DE, Caras GJ. Isoniazid-related hepatitis: a United States Public Health Service Cooperative Surveillance Study. Am Rev Respir Dis 1978;117:991-1001.PubMed Kopanoff DE, Snider DE, Caras GJ. Isoniazid-related hepatitis: a United States Public Health Service Cooperative Surveillance Study. Am Rev Respir Dis 1978;117:991-1001.PubMed
go back to reference Starke JR, Correa AG. Management of mycobacterial infection and disease in children. Pediatr Infect Dis J 1995;14:455-70.CrossRef Starke JR, Correa AG. Management of mycobacterial infection and disease in children. Pediatr Infect Dis J 1995;14:455-70.CrossRef
go back to reference Ormerod LP. Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing. Arch Dis Child 1987;62:1005-8.CrossRef Ormerod LP. Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing. Arch Dis Child 1987;62:1005-8.CrossRef
go back to reference Jasmer RM, Saukkonen JJ, Blumberg HM, et al. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Ann Intern Med 2002;137:640-7.CrossRef Jasmer RM, Saukkonen JJ, Blumberg HM, et al. Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trial. Ann Intern Med 2002;137:640-7.CrossRef
go back to reference Hest R van, Baars H, Kik S, et al. Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment. Clin Infect Dis 2004;39:488-96.CrossRef Hest R van, Baars H, Kik S, et al. Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment. Clin Infect Dis 2004;39:488-96.CrossRef
go back to reference Magdorf K, Arizzi-Rusche AF, Geiter LJ, et al. Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood-a pilot project [in German]. Pneumologie 1994;48:761-4.PubMed Magdorf K, Arizzi-Rusche AF, Geiter LJ, et al. Compliance and tolerance of new antitubercular short-term chemopreventive regimens in childhood-a pilot project [in German]. Pneumologie 1994;48:761-4.PubMed
go back to reference American Academy of Paediatrics. Tuberculosis. In: Red Book: Report of the Committee on Infectious Diseases, 25th ed. Elk Groove Village: American Academy of Paediatrics, 2000. American Academy of Paediatrics. Tuberculosis. In: Red Book: Report of the Committee on Infectious Diseases, 25th ed. Elk Groove Village: American Academy of Paediatrics, 2000.
go back to reference Centers for Disease Control and Prevention. Management of persons exposed to multi-drug tuberculosis. MMWR Morb Mort Wkly Rep 1992;41(RR-II):61-71. Centers for Disease Control and Prevention. Management of persons exposed to multi-drug tuberculosis. MMWR Morb Mort Wkly Rep 1992;41(RR-II):61-71.
go back to reference Passanante MR, Gallagher CT, Reichman LB. Preventive therapy for contacts of multi-drug resistant tuberculosis. Chest 1994;106:431-4.CrossRef Passanante MR, Gallagher CT, Reichman LB. Preventive therapy for contacts of multi-drug resistant tuberculosis. Chest 1994;106:431-4.CrossRef
go back to reference Trebucq A. Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature. Int J Tuberc Lung Dis 1997;1:12-5.PubMed Trebucq A. Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature. Int J Tuberc Lung Dis 1997;1:12-5.PubMed
Metagegevens
Titel
De diagnostiek en behandeling van latente tuberculose-infectie in kinderen
Auteurs
N A. H. van Hest
R. van Altena
S. M. Arend
H. W. M. Baars
J. H. van Loenhout-Rooyackers
N. G. Hartwig
Publicatiedatum
01-02-2006
Uitgeverij
Bohn Stafleu van Loghum
Gepubliceerd in
Tijdschrift voor Kindergeneeskunde / Uitgave 1/2006
Print ISSN: 0376-7442
Elektronisch ISSN: 1875-6840
DOI
https://doi.org/10.1007/BF03061601